<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35818362</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2328-8957</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Open forum infectious diseases</Title><ISOAbbreviation>Open Forum Infect Dis</ISOAbbreviation></Journal><ArticleTitle>The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network.</ArticleTitle><Pagination><StartPage>ofac228</StartPage><MedlinePgn>ofac228</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ofac228</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ofid/ofac228</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Coronavirus disease 2019 (COVID-19) vaccines have been proven to decrease the severity of acute-phase infection; however, little is known about their effect on postacute sequelae of COVID-19 (PASC).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Patients with confirmed COVID-19 diagnosis and minimum age of 18 years with 3-month follow-up postdiagnosis between 21 September 2020 and 14 December 2021 were identified from the TriNetX Research Network platform. The primary outcomes consisted of new-onset or persistent symptoms, new-onset diagnoses, and death and were compared between vaccine and no-vaccine groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">At baseline, 1&#x2009;578&#x2009;719 patients with confirmed COVID-19 were identified and 1.6% (n&#x2009;=&#x2009;25&#x2009;225) completed vaccination. After matching, there were no differences (<i>P</i>&#x2009;&gt;&#x2009;.05) in demographics or preexisting comorbidities. At 28 days following COVID-19 diagnosis, the incidence of hypertension was 13.52 per 1000, diabetes was 5.98 per 1000, thyroid disease was 3.80 per 1000, heart disease was 15.41 per 1000, and mental disorders was 14.77 per 1000 in the vaccine cohort. At 90 days following COVID-19 diagnosis, the relative risk of hypertension was 0.33 (95% confidence interval [CI], .26-.42), diabetes was 0.28 (95% CI, .20-.38), heart disease was 0.35 (95% CI, .29-.44), and death was 0.21 (95% CI, .16-.27). Differences in both 28- and 90-day risk between the vaccine and no-vaccine cohorts were observed for each outcome, and there was enough evidence (<i>P</i>&#x2009;&lt;&#x2009;.05) to suggest that these differences were attributed to the vaccine.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our data suggest that COVID-19 vaccine is protective against PASC symptoms, new onset of health conditions, and mortality.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zisis</LastName><ForeName>Sokratis N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durieux</LastName><ForeName>Jared C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Clinical Research Center, University Hospitals Health System, Cleveland, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mouchati</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Jamie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Clinical Research Center, University Hospitals Health System, Cleveland, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McComsey</LastName><ForeName>Grace A</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0003-2690-8888</Identifier><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002548</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 TR004528</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Open Forum Infect Dis</MedlineTA><NlmUniqueID>101637045</NlmUniqueID><ISSNLinking>2328-8957</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">postacute sequelae of COVID&#x2013;19</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35818362</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pii">ofac228</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Health Organization.  &#xa0;WHO coronavirus (COVID-19) dashboard with vaccination data. https://covid19.who.int/. Accessed 12 January 2022.</Citation></Reference><Reference><Citation>Nalbandian &#xa0;A, Sehgal &#xa0;K, Gupta &#xa0;A, et al. &#xa0;Post-acute COVID-19 syndrome. Nat Med &#xa0;2021; 27:601&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; &#xa0;A, Bernabei &#xa0;R, Landi &#xa0;F. Persistent symptoms in patients after acute COVID-19. JAMA &#xa0;2020; 324:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis &#xa0;HE, Assaf &#xa0;GS, McCorkell &#xa0;L, et al. &#xa0;Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine &#xa0;2021; 38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang &#xa0;C, Wang &#xa0;Y, Li &#xa0;X, et al. &#xa0;Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet &#xa0;2020; 395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie &#xa0;T, Hittle &#xa0;M, Goodman &#xa0;SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open &#xa0;2021; 4:e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal &#xa0;M, Abo Omirah &#xa0;M, Hussein &#xa0;A, Saeed &#xa0;H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract &#xa0;2021; 75:e13746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xfc;rkta&#x15f; &#xa0;H, O&#x11f;uz&#xfc;lgen &#xa0;K. Post-COVID-19 pulmonary sequela: longterm follow up and management [in Turkish]. Tuberk Toraks &#xa0;2020; 68:419&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">33448739</ArticleId></ArticleIdList></Reference><Reference><Citation>Asly &#xa0;M, Hazim &#xa0;A. Rehabilitation of post-COVID-19 patients. Pan Afr Med J &#xa0;2020; 36:1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467884</ArticleId><ArticleId IdType="pubmed">32952812</ArticleId></ArticleIdList></Reference><Reference><Citation>Davido &#xa0;B, Seang &#xa0;S, Barizien &#xa0;N, Tubiana &#xa0;R, de Truchis &#xa0;P. Post-COVID-19 chronic symptoms&#x2014;author&#x2019;s reply. Clin Microbiol Infect &#xa0;2021; 27:495&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7474820</ArticleId><ArticleId IdType="pubmed">32898714</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne &#xa0;T, Crewther &#xa0;S. Post-COVID 19 neurological syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J Neurol Sci &#xa0;2020; 419:117179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550857</ArticleId><ArticleId IdType="pubmed">33070003</ArticleId></ArticleIdList></Reference><Reference><Citation>
United Nations News . COVID &#x2018;Shot for All&#x2019;, not a luxury, but development priority. 2021. https://news.un.org/en/story/2021/09/1100552. Accessed 12 January 2022.</Citation></Reference><Reference><Citation>Polack &#xa0;FP, Thomas &#xa0;SJ, Kitchin &#xa0;N, et al. &#xa0;Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med &#xa0;2020; 383:2603&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Yek &#xa0;C, Warner &#xa0;S, Wiltz &#xa0;JL, et al. &#xa0;Risk factors for severe COVID-19 outcomes among persons aged &#x2265;18 years who completed a primary COVID-19 vaccination series&#x2014;465 health care facilities, United States, December 2020&#x2013;October 2021. MMWR Morb Mortal Wkly Rep &#xa0;2022; 71:19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8735560</ArticleId><ArticleId IdType="pubmed">34990440</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase &#xa0;E. Covid-19: vaccinated people are less likely to get long covid, review finds. BMJ &#xa0;2022; 376:o407.</Citation><ArticleIdList><ArticleId IdType="pubmed">35172970</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre &#xa0;CH, Murray &#xa0;B, Varsavsky &#xa0;T, et al. &#xa0;Attributes and predictors of long COVID. Nat Med &#xa0;2021; 27:626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao &#xa0;Y-M, Shang &#xa0;Y-M, Song &#xa0;W-B, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine &#xa0;2020; 25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal &#xa0;U, Katikireddi &#xa0;SV, McCowan &#xa0;C, et al. &#xa0;COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2.57 million people in Scotland (EAVE II): a prospective cohort study. Lancet Respir Med &#xa0;2021; 9:1439&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8480963</ArticleId><ArticleId IdType="pubmed">34599903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino &#xa0;F, Amiel &#xa0;SA, Zimmet &#xa0;P, et al. &#xa0;New-onset diabetes in Covid-19. N Engl J Med &#xa0;2020; 383:789&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304415</ArticleId><ArticleId IdType="pubmed">32530585</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquot &#xa0;N, Radermecker &#xa0;RP. COVID-19 and diabetes. Annu Rev Med &#xa0;2021; 75:138&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">33211437</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen &#xa0;G, Li &#xa0;X, Gong &#xa0;Z, et al. &#xa0;Hypertension as a sequela in patients of SARS-CoV-2 infection. PLoS One &#xa0;2021; 16:e0250815.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8081193</ArticleId><ArticleId IdType="pubmed">33909683</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya &#xa0;AA, Akbari &#xa0;A, Emami &#xa0;A, et al. &#xa0;Risk factors associated with long COVID syndrome: a retrospective study. Iran J Med Sci &#xa0;2021; 46:428&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminian &#xa0;A, Bena &#xa0;J, Pantalone &#xa0;KM, Burguera &#xa0;B. Association of obesity with postacute sequelae of COVID-19. Diabetes Obes Metab &#xa0;2021; 23:2183&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239834</ArticleId><ArticleId IdType="pubmed">34060194</ArticleId></ArticleIdList></Reference><Reference><Citation>Popkin &#xa0;BM, Du &#xa0;S, Green &#xa0;WD, et al. &#xa0;Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev &#xa0;2020; 21:e13128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461480</ArticleId><ArticleId IdType="pubmed">32845580</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan &#xa0;N, Birkenfeld &#xa0;AL, Schulze &#xa0;MB. Global pandemics interconnected&#x2014;obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol &#xa0;2021; 17:135&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">33479538</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang &#xa0;HK, Bukhari &#xa0;K, Peng &#xa0;CCH, et al. &#xa0;The J-shaped relationship between body mass index and mortality in patients with COVID-19: a dose-response meta-analysis. Diabetes Obes Metab &#xa0;2021; 23:1701&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250762</ArticleId><ArticleId IdType="pubmed">33764660</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardiner &#xa0;J, Oben &#xa0;J, Sutcliffe &#xa0;A. Obesity as a driver of international differences in COVID-19 death rates. Diabetes Obes Metab &#xa0;2021; 23:1463&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013490</ArticleId><ArticleId IdType="pubmed">33620765</ArticleId></ArticleIdList></Reference><Reference><Citation>Smati &#xa0;S, Tramunt &#xa0;B, Wargny &#xa0;M, et al. &#xa0;Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: results from the CORONADO study. Diabetes Obes Metab &#xa0;2021; 23:391&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675375</ArticleId><ArticleId IdType="pubmed">33051976</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters &#xa0;SAE, MacMahon &#xa0;S, Woodward &#xa0;M. Obesity as a risk factor for COVID-19 mortality in women and men in the UK biobank: comparisons with influenza/pneumonia and coronary heart disease. Diabetes Obes Metab &#xa0;2021; 23:258&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536945</ArticleId><ArticleId IdType="pubmed">32969132</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo &#xa0;X, Jiaerken &#xa0;Y, Shen &#xa0;Z, et al. &#xa0;Obese COVID-19 patients show more severe pneumonia lesions on CT chest imaging. Diabetes Obes Metab &#xa0;2021; 23:290&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537264</ArticleId><ArticleId IdType="pubmed">32945051</ArticleId></ArticleIdList></Reference><Reference><Citation>McEwen &#xa0;AE, Cohen &#xa0;S, Bryson-Cahn &#xa0;C, et al. &#xa0;Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State. Clin Infect Dis &#xa0;2021; 74:1089&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394820</ArticleId><ArticleId IdType="pubmed">34166484</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>